+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China



Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China



Biomed Research International 2015: 419392



Several species of rapidly growing mycobacteria (RGM) are now recognized as human pathogens. However, limited data on effective drug treatments against these organisms exists. Here, we describe the species distribution and drug susceptibility profiles of RGM clinical isolates collected from four southern Chinese provinces from January 2005 to December 2012. Clinical isolates (73) were subjected to in vitro testing with 31 antimicrobial agents using the cation-adjusted Mueller-Hinton broth microdilution method. The isolates included 55 M. abscessus, 11 M. fortuitum, 3 M. chelonae, 2 M. neoaurum, and 2 M. septicum isolates. M. abscessus (75.34%) and M. fortuitum (15.07%), the most common species, exhibited greater antibiotic resistance than the other three species. The isolates had low resistance to amikacin, linezolid, and tigecycline, and high resistance to first-line antituberculous agents, amoxicillin-clavulanic acid, rifapentine, dapsone, thioacetazone, and pasiniazid. M. abscessus and M. fortuitum were highly resistant to ofloxacin and rifabutin, respectively. The isolates showed moderate resistance to the other antimicrobial agents. Our results suggest that tigecycline, linezolid, clofazimine, and cefmetazole are appropriate choices for M. abscessus infections. Capreomycin, sulfamethoxazole, tigecycline, clofazimine, and cefmetazole are potentially good choices for M. fortuitum infections. Our drug susceptibility data should be useful to clinicians.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057664252

Download citation: RISBibTeXText

PMID: 26351633

DOI: 10.1155/2015/419392


Related references

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrobial Agents and ChemoTherapy 22(2): 186-192, 1982

In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents. International Journal of Clinical and Experimental Medicine 8(9): 15423-15431, 2015

Susceptibility to antimicrobial agents of rapidly growing mycobacteria. Revista Espanola de Quimioterapia 20(4): 429-432, 2008

In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: Resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates. APMIS 101(1): 27-32, 1993

Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. Bmc Infectious Diseases 17(1): 197, 2017

In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine. Australian Veterinary Journal 93(1-2): 40-45, 2015

Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre. Indian Journal of Medical Microbiology 28(1): 48-50, 2010

Drug susceptibility testing of rapidly growing mycobacteria in extrapulmonary tuberculosis. Indian Journal of Tuberculosis 63(2): 119-122, 2017

Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates. Diagnostic Microbiology & Infectious Disease. : 183-186, 1994

Utilization of potassium tellurite by rapidly growing mycobacteria as a means of drug-susceptibility testing. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 80, 1996

Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents. Biomed Research International 2017: 1584658, 2018

Rapid radiometric method of testing susceptibility of mycobacteria and slow-growing fungi to antimicrobial agents. Antimicrobial Agents and ChemoTherapy 6(1): 29-33, 1974

Antimicrobial susceptibility of rapidly growing mycobacteria using the rapid colorimetric method. European Journal of Clinical Microbiology and Infectious Diseases 34(7): 1403-1413, 2016

The rapidly growing mycobacteria: Characterization and susceptibility testing. Antimicrobic Newsletter 2(12): 85-92, 1985

Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin. Veterinary Microbiology 153(3-4): 240-245, 2012